Hematology Analyzers and Reagents Market: Technological advancements and Recent DevelopmentsPosted by snehal shaha on February 21st, 2023 Introduction The rising prevalence of chronic diseases, such as anemia and leukemia, is a major factor driving the growth of the hematology analyzers market. Additionally, the increasing demand for point-of-care testing, which is expected to reduce the time required for diagnosis, is expected to fuel market growth. Furthermore, technological advancements, such as the introduction of automated hematology analyzers, are also expected to drive market growth. Global Hematology Analyzers and Reagents Market Overview The report Hematology Analyzers and Reagents Market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9% during the forecast period. The increasing incidence of blood disorders and the growth in the number of blood donation are the major factors driving the growth of the global hematology analyzers and reagents market. Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period. Ask for PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146 Market Segmentation: - On the basis of products & services, the hematology reagents market is classified into hematology, hemostasis, and immunohematology products & services. The hematology products & services segment is projected to grow at the highest growth rate during the forecast period. By end user, the hematology analyzers market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market due to factors such as the increasing awareness about hematology testing, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management of sample collection). Regional Analysis: - North America accounted for the largest share of the market in 2019. This can be attributed to the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the rising demand for blood transfusions in the region. Request for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146 Recent Developments: -
Top Key Players: - The major players in the global hematology reagents market are Sysmex Corporation (Japan), Abbott Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland). Like it? Share it!More by this author |